{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:05:04Z","timestamp":1768482304415,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.cccn.2005.05.022","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T14:48:06Z","timestamp":1120315686000},"page":"176-181","source":"Crossref","is-referenced-by-count":5,"title":["Age dependent assessment of TFPI levels in follicular fluid of women undergoing IVF"],"prefix":"10.1016","volume":"361","author":[{"given":"Elmar","family":"Thyzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Siegling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Rudolf","family":"Tinneberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"G\u00f6tting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Kleesiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2005.05.022_bib1","first-page":"269","article-title":"Tissue factor pathway inhibitor (TFPI): biochemistry, genetics and implications for thrombophilia","volume":"25","author":"Brinkmann","year":"2001","journal-title":"J Lab Med"},{"key":"10.1016\/j.cccn.2005.05.022_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor (review)","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cccn.2005.05.022_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.cccn.2005.05.022_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V69.2.645.645","article-title":"Rapaport SI Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation","volume":"69","author":"Rao","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.cccn.2005.05.022_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0049-3848(03)00210-X","article-title":"Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid","volume":"109","author":"Thyzel","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.cccn.2005.05.022_bib6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1055\/s-0038-1653884","article-title":"Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions","volume":"73","author":"Osterud","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cccn.2005.05.022_bib7","first-page":"313","article-title":"Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs","volume":"32","author":"Brinkmann","year":"1994","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.cccn.2005.05.022_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.82.2.644","article-title":"The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome","volume":"82","author":"Fulghesu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cccn.2005.05.022_bib9","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cccn.2005.05.022_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00001721-199203040-00011","article-title":"The present status of tissue factor pathway inhibitor","volume":"3","author":"Lindahl","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cccn.2005.05.022_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.ATV.13.7.1066","article-title":"Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with LP(a)","volume":"13","author":"Lesnik","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.cccn.2005.05.022_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.ATV.14.2.223","article-title":"Tissue factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma","volume":"14","author":"Hansen","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.cccn.2005.05.022_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.cccn.2005.05.022_bib14","series-title":"Reproduction in mammals and man","first-page":"281","article-title":"Ovarian function","author":"Driancourt","year":"1993"},{"key":"10.1016\/j.cccn.2005.05.022_bib15","series-title":"The physiology of reproduction","first-page":"387","article-title":"Follicular selection and its control","author":"Greenwald","year":"1988"},{"key":"10.1016\/j.cccn.2005.05.022_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0015-0282(99)00635-4","article-title":"Human ovarian fluid has functional systems for the generation and modulation of thrombin","volume":"73","author":"Gentry","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cccn.2005.05.022_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/molehr\/8.12.1079","article-title":"High xylosyltransferase activities in human follicular fluid and cultured granulosa-lutein cells","volume":"8","author":"G\u00f6tting","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1095\/biolreprod64.6.1739","article-title":"Hypocoaguable state of human preovulatory ovarian follicular fluid: role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid","volume":"64","author":"Shimada","year":"2001","journal-title":"Biol Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01204048","article-title":"Ovarian hyperstimulation syndrome: a review of pathophysiology","volume":"9","author":"Bergh","year":"1992","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.cccn.2005.05.022_bib20","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/humrep\/14.9.2181","article-title":"Debate: an \u2018epidemic\u2019 of severe OHSS: a price we have to pay?","volume":"14","author":"Abramov","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.cccn.2005.05.022_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1507\/endocrj.50.515","article-title":"Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats","volume":"50","author":"Ishikawa","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.cccn.2005.05.022_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-9378(67)90137-8","article-title":"Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment","volume":"98","author":"Rabau","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cccn.2005.05.022_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)43508-9","article-title":"Ovarian hyperstimulation syndrome: a current survey","volume":"30","author":"Schenker","year":"1978","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cccn.2005.05.022_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.cccn.2005.05.022_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(97)81520-8","article-title":"Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization","volume":"68","author":"Lee","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cccn.2005.05.022_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/17.1.107","article-title":"Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome","volume":"17","author":"Raziel","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.mbc.0000061296.28953.d0","article-title":"Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome","volume":"14","author":"Rogolino","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cccn.2005.05.022_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","article-title":"Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization","volume":"71","author":"Enskog","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cccn.2005.05.022_bib30","first-page":"1353","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study","volume":"8","author":"Delvigne","year":"1993","journal-title":"Clinical and biological features. Hum Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/oxfordjournals.humrep.a137642","article-title":"Ovarian hyperstimulation syndrome after superovulation using GnRh agonists for IVF and related procedures","volume":"7","author":"Rizk","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cccn.2005.05.022_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V74.1.201.201","article-title":"Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay","volume":"74","author":"Warr","year":"1989","journal-title":"Blood"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898105003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:38:06Z","timestamp":1586317086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898105003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0009898105003104"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2005.05.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}